Ibalizumab Biosimilar Antibody
Ibalizumab is a humanized IgG4 monoclonal antibody that blocks HIV-1 entry by binding to a conformational epitope on CD4.
- The description claims that ibalizumab binds to a conformational epitope on CD4.
Specifications
- Antibody Production Scale
- 50 ug, 250 ug, 1 mg
- Conjugate
- None, FITC, HRP, ADC (custom drug)
AI Readiness
Good foundation, but some important product data is still missing.
74%